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A B S T R A C T
The present study focused on the anti-inflammatory screening of Luzula species native to the Carpathian Basin and bioac-
tivity-guided isolation of compounds of Luzula luzuloides (Lam.) Dandy & Wilmott. The anti-inflammatory properties
of extracts with different polarity prepared from Luzula species were determined. Among them, the CH2Cl2-soluble frac-
tion of L. luzuloides possessed strong inhibitory effects on superoxide anion generation (99.39 ± 0.37%) and elastase
release (114.22 ± 3.13%) in fMLP/CB-induced human neutrophils at concentration of 10 μg/mL. From this fraction, six
compounds (1–6) were isolated by the combination of different chromatographic methods. The structures of the com-
pounds were determined by means of MS, 1D and 2D NMR spectroscopy. The results allowed the identification of
the new 1,6-dihydroxy-2-keto-1,7-dimethyl-8-vinyl-1,2-dihydrophenanthrene (1) from the plant, named luzulin A. Chi-
ral HPLC and HPLC-ECD analysis revealed that 1 possesses low enantiomeric excess and TDDFT-ECD calculations
afforded the configurational assignment of the separated enantiomers. Three known phenanthrenes [juncuenin B (2), de-
hydrojuncuenin B (3) and juncusol (4)] and two flavonoids [apigenin (5) and luteolin (6)] were also isolated. The anti-in-
flammatory activity of the isolated compounds was tested and IC50 values were determined. This was the first time that
phenanthrenes were detected in a Luzula species. The oxidative transformation of juncuenin B (3) led to the isolation of
its possible biometabolites, namely luzulin A (1), dehydrojuncuenin B (4), and juncuenin D (7). The isolated compounds
(1–4) confirm that besides flavonoids, phenanthrenes could also serve as chemotaxonomic markers for Luzula species
and prove the close relationship of Juncus and Luzula genus.
© 2016 Published by Elsevier Ltd.
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1. Introduction
The family Juncaceae includes > 500 species, which are distrib-
uted worldwide. Juncus and Luzula are the two largest genera of the
family Juncaceae, comprising approximately 340 and 115 species,
respectively [1,2]. Among them up to 45 species are native to the
Carpathian Basin. Although traditional use of plants belonging to the
genus Luzula has not been reported yet, several Juncus species (e.g. J.
effusus and J. acutus) are used in oriental folk medicine for the treat-
ment of cold, fever, anxiety or insomnia [3–5].
Despite of the comprehensive research focused on Juncaceae fam-
ily, until now only species belonging to the genus Juncus were inves
⁎ Corresponding author.
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tigated extensively [6–9]. There is a significant lack of information
with regards to chemical constituents of the plants belonging to the
genus Luzula. Hitherto only the flavonoid components of Luzula
species were studied. Luteolin and luteolin-7-O-glucoside were iso-
lated by the use of preparative paper chromatography from L. sylvatica
[10]. Williams et al. identified several flavonoids by using TLC, com-
paring their Rf values and colors with standards, and luteolin and lu-
teolin 7-O-glucoside were detected from all of the investigated Luzula
samples (L. arcuata, L. campestris, L. confusa, L. forsteri, L. lactea, L.
multiflora, L. nivea, L. nodulosa, L. nutans, L. pilosa, L. spicata and L.
sylvatica) [11]. Quercetin, procyanidin and other luteolin derivatives
(luteolin 5-methyl ether, luteolin 5-methyl ether 7-O-glucoside) were
also identified in some species [11]. Therefore, flavonoids are consid-
ered to be the main secondary metabolites, and one of the most char-
acteristic components of Luzula species.
http://dx.doi.org/10.1016/j.fitote.2016.12.004
0367-326/© 2016 Published by Elsevier Ltd.
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Previously benzocoumarins, diterpenoids, cycloartane triterpenes,
carotenoids, phenanthrenes, flavonoids, and other phenolic com-
pounds were isolated from Juncus species [12–16]. Apart from
flavonoids, phenanthrenes and 9,10-dihydrophenanthrenes are the
most specific chemical constituents of the family. To date > 90 novel
monomeric and 8 dimeric phenanthrenes have been identified from
Juncaceae species [6–9]. Phenanthrenes are considered to be impor-
tant taxonomic markers, because of their limited occurrence. More-
over, vinylated phenanthrenes have been reported only from species
of the family Juncaceae [6–9]. Phenanthrenes occurring in plants have
drawn considerable interest from the aspect of natural product drug
discovery because of the wide range of their potentially valuable bio-
logical activities, e.g. cytotoxic, antimicrobial and anti-inflammatory
activities [6–9].
Juncus effusus has been used in the traditional oriental medicine
as a remedy for inflammation, therefore, isolated phenanthrenes from
the plant were also tested for their anti-inflammatory activity by the
inhibition of LPS-induced NO production on RAW 264.7 cells and
compounds showed promising effect [17–20]. By the use of this as-
say a strong anti-inflammatory activity was detected in case of ef-
fususin B (IC50 = 7.42 ± 0.50 μM), compared to the positive control
quercetin (IC50 = 6.63 ± 0.28 μM) [17]. 8-Hydroxymethyl-2-hy-
droxy-1-methyl-5-vinyl-9,10-dihydrophenanthrene
(IC50 = 14.42 ± 2.82 μM), 5-(1-methoxyethyl)-1-methylphenan-
threne-2,7-diol (IC50 = 11.10 ± 1.67 μM), effusol
(IC50 = 15.13 ± 0.54 μM), dehydroeffusol (IC50 = 12.69 ± 1.68 μM),
dehydroeffusal (IC50 = 10.50 ± 0.90 μM), 2,7-dihydroxy-5-hydrox-
ymethyl-1-methyl-9,10-dihydrophenathrene
(IC50 = 16.06 ± 1.18 μM), 5-hydroxymethyl-1-methylphenan-
threne-2,7-diol (IC50 = 16.30 ± 2.41 μM), dehydrojuncusol
(IC50 = 15.57 ± 1.08 μM), and the mixture of 2,7-dihydroxy-1,8-di-
methyl-5-vinyl-9,10-dihydrophenanthrene and juncusol
(IC50 = 13.65 ± 1.40 μM) also had remarkable activities in compari-
son with the positive control quercetin [18].
Juncutol displayed noteworthy anti-inflammatory activity by the
inhibition of the iNOS protein expression in LPS-stimulated RAW
264.7 cells. The iNOS level was reduced to 11.2 ± 13.1% from 100%
after treating with 10 μM juncutol [19]. Dehydrojuncusol and its
dimer, 8,8′-bidehydrojuncusol were also assayed by the abovemen-
tioned method. According to the immunoblot analysis, the effect of
dehydrojuncusol on the iNOS protein (41.0 ± 8.0% inhibition at
10 μM) decreased dramatically after dimerization (< 12.0% inhibition
at 10 μM) [20].
The anti-inflammatory activity of flavonoids is well-studied, but in
some cases the mechanism of action of these compounds is not com-
pletely established [21,22]. Apigenin and luteolin inhibited the LPS
induced NO-production on RAW 264.7 macrophages with IC50 val-
ues of 23 μM and 27 μM, respectively. While luteolin reduced the
iNOS expression and interestingly increased the enzyme activity in
a dose-dependent manner, apigenin inhibited the iNOS and COX-2
expression in LPS-activated RAW264.7 cells, but had no effect on
the iNOS enzyme activity [23,24]. Both apigenin and luteolin inhib-
ited significantly the TNF α-induced NF-κB activation on KF 8 cells.
Moreover, their anti-inflammatory activity was confirmed in vivo by
the inhibition of carrageenan-induced paw inflammation on mice [25].
The purposes of the present study were to investigate the anti-in-
flammatory properties of Luzula species, and to perform an activ-
ity-guided fractionation of Luzula luzuloides in order to isolate the
compounds responsible for this effect.
2. Experimental
2.1. General
Normal phase vacuum liquid chromatography (VLC) was carried
out on silica gel (Kieselgel GF254, 15 μm, Merck). LiChroprep RP-18
(40–63 μm, Merck) stationary phase was used for reversed-phase
VLC. Column chromatography (CC) was performed on polyamide
(MP Biomedicals). Sephadex LH-20 (25–100 μm, Pharmacia Fine
Chemicals) was used for gel filtration. Preparative thin-layer chro-
matography (preparative TLC) was carried out on silica gel 60 F254
plates (Merck).
NMR spectra were recorded in CD3OD and DMSO-d6 on a Bruker
Avance DRX 500 spectrometer at 500 MHz (1H) and 125 MHz (13C).
The signals of the deuterated solvents were taken as reference.
Two-dimensional (2D) experiments were performed with a standard
Bruker software. In the COSY, HSQC and HMBC experiments, gra-
dient-enhanced versions were applied. The high resolution MS spec-
tra were acquired on a Thermo Scientific Q-Exactive Plus orbitrap
mass spectrometer equipped with ESI ion source in positive ionization
mode. The resolution was over 1 ppm. The data were acquired and
processed with the MassLynx software. ECD spectra was recorded on
a J-810 spectropolarimeter.
HPLC-ECD analysis: chiral HPLC separation was performed with
a JASCO HPLC system using Chiralpak IA column with
250 mm × 4.6 mm i.d., 5 μm (Daicel, Chemical Industries, Ltd.), and
n-hexane–propan-2-ol eluent at a flow rate of 1.0 mL/min was used.
HPLC-UV and OR chromatograms were recorded with JASCO
MD-910 multiwavelength and OR-2090 Plus chiral detector, respec-
tively. The on-line ECD and UV spectra were measured simultane-
ously by stopping the flow at the UV absorption maximum of each
peak. The values of the ECD ellipticity (ϕ) were not corrected for the
concentration. Three consecutive scans were recorded and averaged
for an HPLC-ECD spectrum with standard sensitivity, 2 nm band-
width and 1 s response. The background HPLC-ECD spectrum of the
eluent was recorded in the same way.
2.2. Plant material
Plants (Luzula campestris (L.) DC., L. forsteri (Sm.) DC., L. luzu-
loides (Lam.) Dandy & Wilmott, L. sudetica (Willd.) Schult., L. syl-
vatica (Huds.) Gaudin) were collected during the flowering period be-
tween June and September 2014, in several regions of the Carpathian
Basin (Hungary, Croatia and Romania). Botanical identification of the
plant material was performed by Gusztáv Jakab (Institute of Envi-
ronmental Sciences, Szent István University, Szarvas, Hungary) and
voucher specimens (No. 869–873) have been deposited at the Depart-
ment of Pharmacognosy, University of Szeged, Szeged, Hungary.
2.3. Preparation of plant samples
For the anti-inflammatory screening assay, extracts were prepared
from 20 g of air-dried plant materials (whole plant, roots and aer-
ial parts) with 5 × 100 mL of MeOH with the use of ultrasonic bath
(5 × 15 min). After filtration, the solutions were evaporated to dryness
under reduced pressure. The residues were dissolved in 50 mL of 50%
aqueous MeOH and subjected to solvent–solvent partition between
n-hexane (3 × 100 mL) (extracts A), dichloromethane (3 × 100 mL)
(extracts B), and EtOAc (3 × 100 mL) (extracts C), and the remaining
H2O extracts gave extracts D.
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2.4. Extraction and isolation
The air-dried whole plant of L. luzuloides (480 g) was percolated
with MeOH (20 L) at room temperature. The crude methanol extract
was concentrated under reduced pressure (76 g) and subjected to sol-
vent–solvent partitioning with CH2Cl2 (2.5 L). After evaporation, the
CH2Cl2 fraction (4.95 g) was chromatographed on a polyamide col-
umn with mixtures of MeOH and H2O [1:1, 4:1 (1 L and 4 L, respec-
tively); each eluent was collected as a fraction]. The fraction obtained
from the polyamide column with methanol–water 4:1 (1.10 g) was fur-
ther chromatographed by VLC on silica gel with a gradient system
of cyclohexane–EtOAc–EtOH [from 9:1:0 to 5:5:1 (300 mL/eluent),
and finally with EtOH (200 mL); volume of collected fractions was
20 mL] to yield twelve major fractions (1 − 12).
From fraction 1 (9.2 mg) compound 2 (5.2 mg) was crystallized.
Fraction 4 (31.3 mg) was purified by Sephadex LH-20 gel chromatog-
raphy using MeOH as eluent [(100 mL); volume of collected frac-
tions was 2 mL] to afford four subfractions (4/1–4). Compound 1
(3.0 mg) was purified from subfraction 4/1 by preparative TLC using
n-hexane–EtOAc (7:3) as solvent system. Subfraction 4/3 (14.1 mg)
was also purified by preparative TLC on silica gel, with cyclo-
hexane–EtOAc–MeOH (20:10:1) as solvent system to afford com-
pound 3 (5.1 mg). Compound 4 (3.2 mg) was crystallized from sub-
fraction 4/4. Fraction 6 (25.1 mg) was separated by RP-VLC, with
a gradient system of MeOH–H2O [from 4:6 to 9:1 (150 mL/eluent),
and finally with MeOH (100 mL); volume of collected fractions was
10 mL] to yield five subfractions (6/1–5). Compound 5 (9.0 mg) was
crystallized from subfraction 6/2. Furthermore, compound 6 (7.1 mg)
was crystallized from fraction 7.
2.4.1. Luzulin A (1)
Amorphous solid; [α]D
26 0 (c 0.1, MeOH); 1H and 13C NMR data,
see Table 2; (+)-HRESIMS m/z 281.1175 [M + H]+ (calcd for
C18H17O3, 281.1177). 25% ee with an excess of (S)-1.
(R)-1: tR = 4.88 min on Chiralpak IA column
(n-hexane–propan-2-ol, 8:2); HPLC-ECD {n-hexane–propan-2-ol,
8:2, λ [nm] (ϕ)}: 424 (2.30), 376 (− 4.49), 312 (− 3.51), 287 (0.10),
266 (− 2.52), 244sh (3.92), 229 (5.17), 204 (− 7.81).
(S)-1: tR = 5.41 min on Chiralpak IA column
(n-hexane–propan-2-ol, 8:2); HPLC-ECD {n-hexane–propan-2-ol,
9:1, λ [nm] (ϕ)}: 424 (− 2.96), 374 (4.26), 312 (2.68), 287 (− 1.23),
268 (1.53), 244sh (− 7.57), 227 (− 8.36), 204 (5.46).
2.5. Oxidation of juncuenin B
50.0 mg of juncuenin B (3) was dissolved in CH3CN–H2O (9:1,
50 mL). 2 eq. [bis(trifluoroacetoxy)iodo]benzene (PIFA) (106.1 mg)
was added to the solution in a careful manner to prevent sudden
boiling. The reaction was monitored by TLC using cyclo-
hexane–EtOAc–EtOH (20:10:1) as solvent system. After 30 min of
stirring at room temperature, all of the starting material, juncuenin B
(3) was converted. The mixture was cooled down in an ice bath, and
evaporated at room temperature.
2.6. Separation of the oxidative products of juncuenin B
The concentrated mixture was chromatographed by VLC on sil-
ica gel (25 mm × 100 mm) with a gradient system of CH2Cl2–acetone
[from 99:1 to 7:3 (200 mL/eluent), and finally with MeOH (150 mL);
volume of collected fractions was 20 mL] to yield seven major frac-
tions (1–7). Dehydrojuncuenin B (4) (8.9 mg) was purified from frac-
tion 2 after gel filtration on Sephadex LH-20 using MeOH–CH2Cl2
(3:1) as eluent [(60 mL); volume of collected fractions was 3 mL].
Fraction 4 was further separated by gel filtration on Sephadex LH-20
using MeOH as eluent [(50 mL); volume of collected fractions was
2 mL] to afford three subfractions (4/1–3). From subfraction 4/2
luzulin A (1) (8.1 mg) was obtained by the use of preparative TLC
using toluene–acetone (8:2) as solvent system. Juncuenin D (7)
(11.2 mg) was isolated from fraction 6 after gel filtration on Sephadex
LH-20 using MeOH–CH2Cl2 (3:1) as eluent [(50 mL); volume of col-
lected fractions was 2 mL]. The compounds were identified according
to their TLC patterns and the comparison of their 1H NMR spectrum
with literature data [5].
2.7. Preparation of human neutrophils
Blood was taken from healthy human donors (20–30 years old) by
venipuncture using a protocol approved by the Institutional Review
Board at Chang Gung Memorial Hospital. Neutrophils were isolated
using a standard method as previously described [26,27]. The cells
were obtained from peripheral blood according to the standard method
of dextran sedimentation, followed by centrifugation in a Ficoll-Hy-
paque gradient and the hypotonic lysis of the erythrocytes. The pu-
rified neutrophils contained > 98% of viable cells, as determined by
Trypan blue exclusion, and were suspended in calcium-free HBSS at
4 °C before used.
2.8. Measurement of superoxide generation
SOD inhibition was measured by reduction of ferricytochrome c
[26,27]. Neutrophils (6 × 105 cells/mL) in 0.5 mg/mL ferricytochrome
c and 1 mM Ca2 + were equilibrated at 37 °C for 2 min and then incu-
bated with drugs for 5 min. The cells were activated using formyl-me-
thionyl-leucyl-phenylalanine (fMLP, 100 nM)/cytochalasin B (CB,
1 μg/mL) for 10 min. The absorbance was continuously monitored at
550 nm using a double-beam, six-cell positioned spectrophotometer
with constant stirring (Hitachi U-3010, Tokyo, Japan). Calculations
were based on the differences in absorbance with and without SOD
(100 μ/mL) divided by the extinction coefficient for the reduction of
ferricytochrome c (ε = 21.1/mM/10 mm).
2.9. Measurement of elastase release
The degranulation of azurophilic granules was determined by elas-
tase release as described previously [26,27]. Neutrophils (6 × 105/mL)
were equilibrated in MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide
(100 μM), an elastase substrate, at 37 °C for 2 min and then incubated
with drugs for 5 min. The cells were activated using fMLP (100 nM)
in the presence of CB (0.5 μg/mL), and changes in the absorbance at
405 nm were continuously measured to monitor elastase release. The
results are expressed as a percentage of elastase release in the fMLP/
CB-activated, drug-free control system.
2.10. Statistical methods
Results of the anti-inflammatory assays were expressed as
means ± S.E.M. Statistical analysis using Student's t-test was per-
formed with SigmaPlot (Systat Software, San Jose, CA, USA). A
value of P < 0.05 was considered statistically significant.
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2.11. Computational section
Mixed torsional/low-frequency mode conformational searches
were carried out by means of the Macromodel 9.9.223 software us-
ing the Merck Molecular Force Field (MMFF) with an implicit solvent
model for CHCl3 [28]. Geometry reoptimizations were carried out at
the B3LYP/6-31G(d) level in vacuo, the B97D/TZVP [29,30] and the
CAM-B3LYP/TZVP [31,32] levels with the PCM solvent model for
CHCl3. TDDFT ECD calculations were run with various functionals
(B3LYP, BH&HLYP, CAM-B3LYP, PBE0) and the TZVP basis set
as implemented in the Gaussian 09 package with the same or no sol-
vent model as in the preceding DFT optimization step [33]. ECD spec-
tra were generated as sums of Gaussians with 3000 cm− 1 widths at
half-height (corresponding to ca. 41 nm at 370 nm), using dipole-ve-
locity-computed rotational strength values [34]. Boltzmann distribu-
tions were estimated from the ZPVE-corrected B3LYP/6-31G(d) en-
ergies in the gas-phase calculations and from the B97D/TZVP and
CAM-B3LYP/TZVP energies in the solvated ones. The MOLEKEL
software package was used for visualization of the results [35–37].
3. Results and discussion
In the course of our screening study, the anti-inflammatory ac-
tivities of 5 species of the Luzula genus native to the Carpathian
Basin were evaluated. The results of the assays are listed in Table
1. Extracts were prepared with methanol from whole plants of L.
campestris, L. forsteri, L. luzuloides and L. sudetica. The plant mater
Table 1
Inhibitory effects of extracts with different polarity from Luzula species on superoxide
anion generation and elastase release by human neutrophils in response to fMLP/CB at
concentration 10 μg/mL.
Species Fraction
Yield
(w/w
%)
Superoxide anion
inhibition (%)
Elastase inhibition
(%)
Luzula campestris (L.)
DC.
A 8.06 50.04 ± 5.08*** 106.98 ± 6.35***
B 3.55 96.06 ± 0.91*** 112.19 ± 6.16***
C 7.42 77.45 ± 6.44*** 84.22 ± 4.09***
D 54.84 32.52 ± 5.43*** 45.18 ± 6.47***
L. forsteri (Sm.) DC. A 10.54 71.53 ± 7.75*** 71.88 ± 7.07***
B 6.67 93.14 ± 6.14*** 113.51 ± 1.07***
C 46.67 35.24 ± 1.43*** 37.95 ± 6.88**
D 22.67 32.80 ± 3.40*** 54.52 ± 0.99***
L. luzuloides (Lam.)
Dandy & Wilmott
A 23.44 70.65 ± 6.65*** 92.50 ± 3.58***
B 4.69 99.39 ± 0.37*** 114.22 ± 3.13***
C 49.89 62.84 ± 3.50*** 68.39 ± 5.74***
D 11.18 68.80 ± 5.92*** 77.71 ± 4.99***
L. sudetica (Willd.)
Schult.
A 17.86 72.85 ± 6.35*** 76.08 ± 5.45***
B 7.14 109.25 ± 6.01*** 115.21 ± 4.14***
C 17.86 77.95 ± 0.22*** 91.41 ± 1.84***
D 47.62 37.92 ± 5.39** 8.59 ± 3.19
L. sylvatica (Huds.)
Gaudin (aerial part)
A 8.57 85.27 ± 4.20*** 89.10 ± 6.41***
B 5.71 96.09 ± 1.92*** 111.90 ± 2.99***
C 18.10 73.32 ± 2.91*** 54.82 ± 4.11***
D 43.81 26.90 ± 7.01** 48.83 ± 6.51**
L. sylvatica (root part) A 7.96 89.18 ± 6.58*** 107.88 ± 3.96***
B 4.69 95.28 ± 2.48*** 104.23 ± 5.67***
C 46.12 53.62 ± 7.13*** 54.13 ± 3.03***
D 12.65 41.60 ± 6.19*** 43.02 ± 2.96***
A = n-hexane fraction, B = CH2Cl2 fraction, C = EtOAc fraction, D = remaining H2O
fraction.
Results are presented as mean ± S.E.M. (n = 3– 5). **P < 0.01, ***P < 0.001
compared with the control value (DMSO).
ial allowed the separation of L. sylvatica into aerial and root parts,
therefore methanol extracts were prepared from selected plant organs
in case of L. sylvatica. The crude extracts were concentrated and
suspended in 50% MeOH, and then solvent–solvent partitions were
made with n-hexane (A), CH2Cl2 (B), and EtOAc (C). The remain-
ing H2O fractions were signed as D (altogether 24 extracts). The ap-
olar, n-hexane-soluble fractions of L. forsteri, L. luzuloides, L. sudet-
ica and L. sylvatica showed > 70% inhibition at the tested concen-
tration (10 μg/mL) in both anti-inflammatory assays. The fraction A
of L. campestris exerted the most selective elastase release inhibition.
Among the fractions with different polarities, fractions B (containing
CH2Cl2-soluble lipophilic constituents) had the most remarkable ac-
tivities (> 93% inhibition) at concentration of 10 μg/mL. All of the
CH2Cl2-soluble fractions displayed significant activities on the inhi-
bition of elastase release, and proved to be slightly less active on su-
peroxide generation. The EtOAc-soluble fractions of L. campestris, L.
luzuloides, L. sudetica, L. sylvatica (aerial part) possessed notewor-
thy (> 65%) inhibitory activities at concentration of 10 μg/mL. The
remaining H2O fraction of L. luzuloides also showed notable anti-in-
flammatory activities (> 65%) in both methods. On the basis of these
preliminary results, L. luzuloides has been chosen for further investi-
gation.
Dried whole plant material of L. luzuloides (480 g) was powdered
and extracted with methanol at room temperature. After concentration,
the extract was dissolved in 50% aqueous MeOH, and solvent–sol-
vent partition was performed with n-hexane, CH2Cl2, and EtOAc. The
CH2Cl2 fraction was separated and purified with the combination of
different chromatographic methods (CC, VLC, Sephadex LH-20 gel
chromatography, prep TLC) to afford 6 compounds (1–6, Fig. 1).
The structure determination was carried out by extensive spec-
troscopic analysis, using one- and two-dimensional NMR (1H 1H
COSY, HSQC, HMBC) spectroscopy, HRESIMS and HPLC-ECD ex-
periments and comparison of the spectral data with literature data.
Compound 1 was obtained as an amorphous solid with [α]D
26 0 (c
0.1, MeOH). Its HRESIMS provided the molecular formula C18H16O3
through the presence of a peak at m/z 281.1175 [M + H]+ (calcd for
C18H17O3, 281.1172). The
1H NMR spectrum (Table 2) displayed sig-
nals of two pairs of ortho-coupled aromatic protons (δH 6.25 d/8.35
d and δH 8.12 d/7.63 d), and one aromatic proton as a singlet (δH
7.52), two methyl singlets at δH 1.53 and δH 2.35, and a vinylic sys-
tem at δH 5.81, 5.35 and 7.05 (C-14, C-13). In the JMOD spectrum,
the presence of 18 carbon signals was detected (Table 2). In the 1H
NMR spectrum the presence of ortho-coupled aromatic protons at δH
8.12 d and 7.63 d could be assigned to the H-9 and H-10 protons of
a phenanthrene derivative. In the 1H,1H–COSY spectrum four corre-
lations were observed between δH 8.12 d and 7.63 d (H-9/H-10), be-
tween δH 6.25 d and 8.35 d (H-3/H-4), between δH 7.05 dd and 5.81 d
(H-13/H-14a), and between δH 7.05 dd and 5.35 d (H-13/H-14b). The
two ortho-coupled doublets at δH 6.25 and 8.35 were assigned to the
H-3 and H-4 protons. According to the 13C NMR signals at δC 207.1
one carbonyl group was identified, which was placed to C-2 as con-
firmed by HMBC correlations of the 11-CH3 (δH 1.53) and H-4 (δH
8.35 d) with C-2 (δC 207.1) (Table 2, Fig. 2). The location of one of
the methyl groups (δH 1.53 s) was confirmed at C-1 on the basis of
its HMBC correlation with the quaternary carbons δC 146.6 (C-1a),
78.1 (C-1) and 207.1 (C-2). The linkage of hydroxy groups to C-1 and
C-6 was confirmed by the chemical shifts of the quaternary carbons at
δC-1 78.1 and δC-6 157.0, respectively. In the HMBC spectrum another
methyl group was assigned at C-7 by the correlation of H-12/C-7. The
vinyl substitution at C-8 was indicated by the HMBC cross-peaks be-
tween H-14a/C-8 and H-14b/C-8.
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Fig. 1. Structures of compounds 1–7.
The NOESY correlations further confirmed the structure of com-
pound 1. Overhauser effects were detected between H-3/H-4, H-4/
H-5, H-9/H-10, H-9/H-13, H-9/H-14b, H-13/CH3-12, H-14b/CH3-12.
All of the above evidence confirmed the planar structure of 1 named
as luzulin A (Fig. 1).
Luzulin A (1) is a chiral natural product but it had a very weak
ECD spectrum in acetonitrile and zero specific rotation, which sug-
gested that it had low enantiomeric excess. Thus chiral HPLC analysis
of 1 was carried out, which resulted in the separation of the two enan-
tiomers on a Chiralpak IA column and determined the enantiomeric
excess as 25%. The quaternary stereogenic center does not enable in-
version of the absolute configuration during the isolation and hence
the low enantiomeric excess can be attributed to the low enantioselec-
tivity of the biosynthetic step, which has been observed for other nat-
ural phenanthrenes as well [38].
In order to elucidate the absolute configuration of the enantiomers
and identify the major enantiomer, HPLC-ECD spectra of the sepa-
rated enantiomers were recorded and the solution TDDFT-ECD pro-
tocol was applied on the arbitrarily chosen (R) enantiomer (Fig. 3)
[36]. The initial Merck Molecular Force Field (MMFF) conforma-
tional search resulted in 5 conformers in a 21 kJ/mol energy window,
which were reoptimized at various DFT levels [B3LYP/6-31G(d) in
vacuo, B97D/TZVP PCM/CHCl3 and CAM-B3LYP/TZVP PCM/
CHCl3] and ECD spectra were computed with B3LYP, BH&HLYP,
CAM-B3LYP and PBE0 functionals and TZVP basis set. The com-
puted conformers differed in the orientation of the OH-6 proton and
the C-8 vinyl group, the latter of which influenced the ECD spectra
as well. The OH-1 group adopted equatorial position in all the com-
puted conformers (Fig. 4). All the applied combinations for all con-
formers reproduced the first two transitions at ca. 422 and 375 nm and
Boltzmann-weighted spectra acquired at all applied levels resembled
also the high-energy transitions at ca. 227 and 206 nm allowing the
elucidation of the absolute configuration as (R) for the first-eluting
enantiomer (minor component) and (S) for the second-eluting enan-
tiomer (major component). Interestingly, the 312 nm Cotton effect
(CE) could not be reproduced by any applied combination of theo-
retical levels, which can be attributed to difficulties in estimating the
proper orientation of the conjugating quite freely rotating vinyl chro-
mophore and the overlapping transitions of this region [37].
Besides the new compound, luzulin A (1), two dihydrophenan-
threnes [juncusol (2) and juncuenin B (3)], one phenanthrene [dehy-
drojuncuenin B (4)] and two flavonoids [apigenin (5) and luteolin
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Table 2
NMR spectroscopic data for luzulin A (1) (500 MHz, CD3OD).
Position 1
δH (J in Hz) δC, type HMBC (H → C)
1 78.1, C
1a 146.6, C
2 207.1, C
3 6.25, d (10.2) 123.1, CH 1, 4a
4 8.35, d (10.1) 141.9, CH 1a, 2
4a 122.6, C
5 7.52, s 103.3, CH 4a, 6, 8a
5a 132.2, C
6 157.0, C
7 126.3, C
8 138.3, C
8a 127.7, C
9 8.12, d (8.5) 129.8, CH 1a, 5a
10 7.63, d (8.7) 121.0, CH 4a, 8a
11 1.53, s 32.1, CH3 1, 1a, 2
12 2.35, s 13.4, CH3 6, 7, 8
13 7.05, dd (17.9, 11.5) 135.7, CH
14a 5.81, d (11.5) 122.2, CH2 8
14b 5.35, d (18.0) 8
Fig. 2. Diagnostic COSY (▬) and HMBC correlations (→) for 1.
Fig. 3. Experimental HPLC-ECD spectra of 1 (black: first eluting enantiomer; grey:
second eluting enantiomer) compared with the Boltzmann-weighted PBE0/TZVP
(PCM/CHCl3) ECD spectrum of (R)-1 computed for the B97D/TZVP PCM/CHCl3 con-
formers. Bars represent the rotational strength of the lowest-energy conformer.
(6)] were also isolated from L. luzuloides. Their structures were deter-
mined by analyses of MS, 1D and 2D NMR data, and by comparison
with literature data [38–40].
All compounds were isolated for the first time from L. luzuloides.
The methyl group at C-1, a hydroxyl group at C-2 and vinyl, methyl
and hydroxyl substitution on ring B are characteristic features of the
isolated phenanthrenes. In compound 1, a carbonyl group can also be
found in the molecule. The absolute configuration of luzulin A (1) was
determined by HPLC-ECD measurements and TDDFT-ECD calcula-
tions.
So far > 90 novel phenanthrenes have been reported from 6 Juncus
species (J. acutus, J. effusus, J. inflexus, J. roemerianus, J. setchuen-
sis and J. subulatus) [5–7,38]. The first example of nitrogen-free
alkylated phenanthrenes was juncusol (2) isolated from J. roemeri-
anus [41]. Until now phenanthrenes have not been isolated from the
genus Luzula. This was the first time when extensive phytochemical
and pharmacological investigations were performed with the genus
Luzula and with L. luzuloides. Our results allowed the identification
of four phenanthrenes (1–4) substituted with vinyl, hydroxyl, methyl
and methoxy groups, one of them (1) is new natural product. The other
phenanthrenes (2–4) were isolated previously only from other Jun-
caceae species. All of the compounds were isolated for the first time
from L. luzuloides.
In the course of our previous investigations considerable amount
of juncuenin B (3) (850 mg) and its unsaturated form, dehydrojun-
cuenin B (4) have been isolated from J. inflexus [38]. Luzulin A (1)
from L. luzuloides and juncuenin D (7) from J. inflexus have obvi-
ous structure similarity with the abovementioned two phenanthrenes
[juncuenin B (3) and dehydrojuncuenin B (4)], suggesting that both
phenanthrenequinones are possibly derived from the oxidation of jun-
cuenin B (3). In the case of luzulin A (1), ring A is oxidized, and
in the case of juncuenin D (7) ring C has changed. In order to con-
firm their possible biosynthetic connection, juncuenin B (3) was sub-
jected to an oxidative reaction by the use of hypervalent iodine reagent
(PIFA). 50 mg juncuenin B (3) was dissolved in CH3CN–H2O (9:1,
1 mg/mL), and a reaction with 2 eq. of PIFA was performed at room
temperature for 30 min (Scheme 1). After purification by NP-VLC,
Sephadex LH-20 gel filtration and preparative TLC, three major com-
pounds were isolated from the mixture. The compounds were iden-
tified as juncuenin D (7, 22%), dehydrojuncuenin B (4, 18%) and
luzulin A (1, 16%) by comparison of their 1H NMR spectrum with lit-
erature data [5]. These findings confirm that luzulin A (1) and jun-
cuenin D (7) can form by oxidation of juncuenin B (3), and most
probably similar process may be performing during their biosynthesis.
Although, several phenanthrenes and flavonoids have been reported
to exhibit remarkable anti-inflammatory activity, there were no pre-
vious data for the anti-inflammatory effects of metabolites from the
genus Luzula. In the performed assay, effects against superoxide anion
production and elastase release by human neutrophils in response to
fMLP/CB were measured according to previously published methods
[26,27]. Among the isolated compounds, noteworthy anti-inflamma-
tory activities were measured for juncusol (2), juncuenin B (3), dehy-
drojuncuenin B (4), apigenin (5) and luteolin (6) (Table 3). Although
great deals of phenanthrenes were assayed for their anti-inflammatory
properties, this was the first time when the anti-inflammatory activity
of the isolated phenanthrenes (1–4, 7) was evaluated [5,6].
In the superoxide anion generation assay, significant inhibitory ac-
tivities were recorded for juncusol (2) (IC50 = 3.11 μM), juncuenin B
(3) (IC50 = 4.92 μM), dehydrojuncuenin B (4) (IC50 = 3.17 μM), api-
genin (5) (IC50 = 6.12 μM), and luteolin (6) (IC50 = 4.73 μM). Fur-
thermore, juncuenin B (3) and luteolin (6) inhibited effectively the
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Fig. 4. Structures and populations of the B97D/TZVP PCM/CHCl3 conformers of (R)-1.
Scheme 1. Oxidation of juncuenin B (3).
elastase release with IC50s 5.47 μM and 6.91 μM, respectively, com-
parable to that of LY294002 (IC50 = 4.79 μM). These results sug-
gest that compounds 2–6 display promising anti-inflammatory activ-
ity, juncusol (2), dehydrojuncuenin B (4) and apigenin (5) were con-
sidered to be active only in case of inhibition of superoxide generation,
while luzulin A (1) and juncuenin D (7) were proved to be inactive in
both assays. With its unsaturation at ring B, juncuenin B (3) lost its ef-
fect on the elastase release, but dehydrojuncuenin B (4) inhibited the
superoxide generation more effectively than juncuenin B (3). The two
phenanthrenequinones, luzulin A (1) and juncuenin D (7), presumably
derived from juncuenin B (3) showed significantly lower anti-inflam-
matory activities compared to their possible biosynthetic precursor.
In conclusion, phenanthrenes are the most characteristic com-
pounds of Juncaceae species. Although phenanthrenes have been
identified from taxonomically distant families [6], vinyl substituted
derivatives can be considered as chemotaxonomic markers for plants
belonging to Juncaceae family, since these specifically substituted
phenanthrenes were only reported from Juncus species, and this was
the first time when they were isolated from the genus Luzula. The
chemical characterization of L. luzuloides, and the presence of viny-
lated phenanthrenes in the plant further confirm the close botanical re-
lationship between the genera Luzula and Juncus.
This was the first time when the anti-inflammatory activity of
species belonging to the genus Luzula was evaluated. Along with the
extracts prepared from different species of the genus, several isolated
compounds showed promising anti-inflammatory activities. The pre-
sent study highlights that phytochemical and pharmacological studies
of the previously uninvestigated genus Luzula are very promising.
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Table 3
Inhibitory effects of compounds 1–7 on superoxide anion generation and elastase re-
lease by human neutrophils in response to fMLP/CB.
Compound Superoxide anion Elastase release
IC50 (μM) Inhibition (%) IC50 (μM) Inhibition (%)
1 > 10 12.26 ± 3.76* > 10 40.5 ± 5.57**
2 3.11 ± 0.25 93.07 ± 0.48*** > 10 2.05 ± 2.07
3 4.92 ± 0.27 81.54 ± 3.5*** 5.47 ± 1.11 80.57 ± 4.15***
4 3.17 ± 1.19 82.90 ± 7.65*** > 10 25.58 ± 2.83**
5 6.12 ± 0.72 73.92 ± 4.11*** > 10 46.14 ± 6.03**
6 4.73 ± 0.49 79.77 ± 4.37*** 6.91 ± 2.25 54.16 ± 4.66***
7 > 10 43.29 ± 5.77*** > 10 32.75 ± 6.98**
LY294002 1.29 ± 0.05 – 4.97 ± 0.80 –
Percentage of inhibition (inhibition %) at 10 μM concentration. Results are presented
as mean ± S.E.M. (n = 3– 5). *P < 0.05, **P < 0.01, ***P < 0.001 compared with the
control value. LY294002, a PI3K inhibitor, was used as positive control.
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